Exact Sciences Stock and Quanterix Stocks Slip Following Medicare Rates Announcement
Thursday, 26 September 2024, 19:35
The Impact of Medicare Rates on Exact Sciences and Quanterix Stocks
The recent announcement from CMS regarding Medicare rates has sent Exact Sciences (EXAS) stock and Quanterix (QTRX) stocks tumbling. Investors had anticipated better preliminary payment rates for diagnostic tests, which ultimately did not materialize.
Market Reactions
- Both stocks faced immediate sell-offs.
- Analysts are now reassessing growth projections for Exact Sciences and Quanterix.
Future Outlook
With Medicare adjusting its payment rates, investors must closely observe how these changes will affect the long-term viability and strategies of both companies.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.